| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |